Major Study Finds No Direct Link Between Antidepressant Use in Pregnancy and Autism or ADHD Risk

A comprehensive international study involving over 600,000 pregnant women and published in The Lancet Psychiatry has brought new insights into the effects of antidepressants during pregnancy on child neurodevelopment. The research compiled data from 37 studies and initially noted a slight increase in the risk of autism spectrum disorder and ADHD among children exposed to antidepressants in utero. However, once genetic factors, family psychiatric history, and parental mental health were accounted for, this association effectively disappeared.

Research led by Wing-Chung Chang from the University of Hong Kong emphasizes that antidepressants themselves do not significantly raise the risk of these disorders. Instead, hereditary and environmental influences, such as genetic predispositions, family mental health conditions, ongoing stress, and family dynamics, play a more substantial role. Interestingly, increased risks were also linked to antidepressant use before pregnancy or paternal use during gestation, suggesting medication is not the direct cause.

The study found no significant difference in risk between high and low doses of antidepressants, alleviating concerns over dosage effects. Experts strongly warn against stopping antidepressant treatment during pregnancy without medical guidance due to potential harm to both mother and child. The findings provide reassuring evidence for families and highlight the importance of individualized treatment plans developed with healthcare professionals.